Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Sees Significant Drop in Short Interest

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) was the target of a significant decrease in short interest during the month of March. As of March 13th, there was short interest totaling 4,398,706 shares, a decrease of 62.9% from the February 26th total of 11,868,383 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Genomma Lab Internacional Price Performance

Shares of OTCMKTS:GNMLF opened at $1.00 on Wednesday. Genomma Lab Internacional has a 1 year low of $0.93 and a 1 year high of $1.43. The business’s 50 day moving average price is $1.01 and its 200-day moving average price is $1.03.

About Genomma Lab Internacional

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.